The therapy of
NON-MUSCLE INVASIVE URBAN CARCINOMAS
according to the S3 guideline in a practical overview.
App as a free download for specialist groups with Doc Check Login!
About this app
• Offers you help with risk classification, therapy and aftercare
• Takes into account the S3 guideline of non-muscle invasive bladder cancer
• Read and commented for you: The publication of the month
The BC Care app from medac is an interactive, mobile aid for identifying the risk group for superficial non-muscle-invasive bladder carcinoma (NMIBC) and provides information for guideline-oriented, risk-adapted therapy. Based on the currently valid S3 guideline on non-muscle-invasive bladder cancer (Ta, T1, CIS), the BC Care app offers valuable support in daily urological practice.
Additional information in the app:
• Technical information on mito-extra® and BCG-medac
• The S3 guideline of 2020
• Glossary of all important HBCA terms
A service of the medac society for clinical specialty products mbH
NON-MUSCLE INVASIVE URBAN CARCINOMAS
according to the S3 guideline in a practical overview.
App as a free download for specialist groups with Doc Check Login!
About this app
• Offers you help with risk classification, therapy and aftercare
• Takes into account the S3 guideline of non-muscle invasive bladder cancer
• Read and commented for you: The publication of the month
The BC Care app from medac is an interactive, mobile aid for identifying the risk group for superficial non-muscle-invasive bladder carcinoma (NMIBC) and provides information for guideline-oriented, risk-adapted therapy. Based on the currently valid S3 guideline on non-muscle-invasive bladder cancer (Ta, T1, CIS), the BC Care app offers valuable support in daily urological practice.
Additional information in the app:
• Technical information on mito-extra® and BCG-medac
• The S3 guideline of 2020
• Glossary of all important HBCA terms
A service of the medac society for clinical specialty products mbH
Show More
